Life Sciences Greenhouse of Pennsylvania

Micro Interventional Devices is developing disruptive technologies that are revolutionizing percutaneous and minimally invasive structural heart repair procedures. Their proprietary technology is based on a breakthrough in soft- tissue anchoring and associated delivery devices that enable off-pump procedures.

MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.

MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.

INDIGO Biosciences supplements the receptor assay kits and services and in vitro toxicology solutions with greater readability, reproducibility, and faster turnaround times of the results. Their solutions, combined with a supportive team and reliable science and platforms, aim to reduce the time, cost, and risk associated with the discovery process.

MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.

MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.

Micro Interventional Devices is developing disruptive technologies that are revolutionizing percutaneous and minimally invasive structural heart repair procedures. Their proprietary technology is based on a breakthrough in soft- tissue anchoring and associated delivery devices that enable off-pump procedures.

Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines for the treatment of allergy and other human health targets. The company was founded in 2005 and is based in Lancaster, Pennsylvania.

INDIGO Biosciences supplements the receptor assay kits and services and in vitro toxicology solutions with greater readability, reproducibility, and faster turnaround times of the results. Their solutions, combined with a supportive team and reliable science and platforms, aim to reduce the time, cost, and risk associated with the discovery process.

NanoHorizons combines science and technology to invent, design, and manufacture advanced nanoparticles that provide permanent, safe, effective, and economical antimicrobial protection in a variety of products.

Novasentis (formerly Strategic Polymer Sciences, Inc.), created the world’s first electro-mechanical polymer (EMP), the thinnest and most flexible haptic actuator and sensor technology today, used to develop mobile and wearable products that come alive with movement and sound. By bridging consumer electronics and sensory interaction, Novasentis enables 4D spatial tactile experiences and next-generation mobile product designs. Novasentis is privately funded. The company is based in San Francisco Bay Area and has offices in Pennsylvania, Korea, and Tokyo. More information on Novasentis is online at www.novasentis.com

INRange Systems develops and supplies remote medication management systems facilitating documented medication administration for hospitals. It offers EMMA, a telehealth medical device for documented and professional medication administration to outpatients with a history of non-adherence to their medication regimens and where strict medication adherence is critical to the treatment. The company was founded in 2002 and is based in Altoona, Pennsylvania.

SoftGenetics provides researchers and clinicians with software analysis tools for genetic analysis. It offers Mutation Surveyor, which provides discovery of DNA variants from sanger sequencing traces; NextGENe, a condensation tool, which polishes and lengthens short sequence reads into fragment sizes; GeneMarker, a genotyping software with application oriented defaults that reduces analysis set-up time; GeneMarker human identity software for various forensic profiling applications; JelMarker, an image reading software; and CGH Explorer for identifying genomic regions with copy number alterations. The company also provides analysis services.

Chaperone Tecnologies is developing antimicrobial products, based on a novel and proprietary mechanism of action, for difficult-to-treat and drug-resistant organisms across a broad range of infectious diseases.

INRange Systems develops and supplies remote medication management systems facilitating documented medication administration for hospitals. It offers EMMA, a telehealth medical device for documented and professional medication administration to outpatients with a history of non-adherence to their medication regimens and where strict medication adherence is critical to the treatment. The company was founded in 2002 and is based in Altoona, Pennsylvania.

Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT.

QuantumBio Inc is a software and services company that provides innovative technical solutions to the life sciences. QuantumBio Inc offers a powerful suite of products built on cutting-edge science that utilizes the highest levels of theory available to achieve high accuracy, performance, and versatility. QuantumBio's tools leverage the precision of quantum mechanical approaches to aid Pharmaceutical, Biotech, and Academic scientists to improve their understanding of biochemical structure and function, while enhancing the drug discovery process.